Cite
HARVARD Citation
Kopylov, U. et al. (2020). Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy. Alimentary pharmacology & therapeutics. 52 (1), pp. 135-142. [Online].